ES8307230A1 - "un procedimiento para la preparacion de oxaprocin calcico". - Google Patents
"un procedimiento para la preparacion de oxaprocin calcico".Info
- Publication number
- ES8307230A1 ES8307230A1 ES511730A ES511730A ES8307230A1 ES 8307230 A1 ES8307230 A1 ES 8307230A1 ES 511730 A ES511730 A ES 511730A ES 511730 A ES511730 A ES 511730A ES 8307230 A1 ES8307230 A1 ES 8307230A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- oxazole derivatives
- oxaprozin
- calcium
- palatable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000007978 oxazole derivatives Chemical class 0.000 title 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 abstract 3
- 229960002739 oxaprozin Drugs 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
UN PROCEDIMIENTO PARA LA PREPARACION DE OXAPROCIN CALCICO. SE HACE REACCIONAR OXAPROZIN PERFECTAMENTE EN FORMA DE SAL SOLUBLE CON UNA FUENTE DE IONES CALCIO; PREFERENTEMENTE SE EMPLEA UNA SAL DE METAL ALCALINO DE OXAPROZIN Y UNA SAL CALCICA ACUOSOLUBLE TAL COMO CLORURO CALCICO EN SOLUCION ACUOSA, DE DONDE SE AISLA EL OXAPROZIN OBTENIDO. PREFERENTEMENTE SE OBTIENE OXAPROZIN TETRAHIDRATADOS. EL COMPONENTE ACTIVO PUEDE SUSPENDERSE EN UN VEHICULO LIQUIDO FARMACEUTICAMENTE ACEPTABLE TAL COMO EL AGUA, UN DISOLVENTE ORGANICO, UNA MEZCLA DE AMBOS O ACEITES O GRASAS FARMACEUTICAMENTE ACEPTABLES. LAS COMPOSICIONES EN FORMA LIQUIDA INCLUYEN SUSPENSIONES, EMULSIONES, JARABES O ELIXIRES. ACTIVIDAD ANTI-INFLAMATORIA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8113074 | 1981-04-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8307230A1 true ES8307230A1 (es) | 1983-07-01 |
| ES511730A0 ES511730A0 (es) | 1983-07-01 |
Family
ID=10521427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES511730A Granted ES511730A0 (es) | 1981-04-28 | 1982-04-27 | "un procedimiento para la preparacion de oxaprocin calcico". |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US4465838A (es) |
| EP (1) | EP0063884B1 (es) |
| JP (1) | JPS57181072A (es) |
| KR (1) | KR880000871B1 (es) |
| AT (1) | ATE14015T1 (es) |
| AU (1) | AU544975B2 (es) |
| CA (1) | CA1169867A (es) |
| CS (1) | CS236674B2 (es) |
| DD (1) | DD202017A5 (es) |
| DE (1) | DE3264400D1 (es) |
| DK (1) | DK150604C (es) |
| ES (1) | ES511730A0 (es) |
| FI (1) | FI71314C (es) |
| GR (1) | GR75913B (es) |
| HU (1) | HU185276B (es) |
| IE (1) | IE52909B1 (es) |
| IL (1) | IL65443A (es) |
| MY (1) | MY8700599A (es) |
| NZ (1) | NZ200247A (es) |
| PH (1) | PH18053A (es) |
| PL (1) | PL136322B1 (es) |
| PT (1) | PT74794B (es) |
| ZA (1) | ZA822355B (es) |
| ZW (1) | ZW7482A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| US6726928B2 (en) * | 1994-10-28 | 2004-04-27 | R.P. Scherer Technologies, Inc. | Process for preparing solid dosage forms for unpalatable pharmaceuticals |
| AU718030B2 (en) * | 1996-05-20 | 2000-04-06 | G.D. Searle & Co. | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| US7358254B2 (en) * | 2001-07-13 | 2008-04-15 | Bristol-Myers Squibb Company | Method for treating atherosclerosis employing an aP2 inhibitor and combination |
| US20060251689A1 (en) * | 2005-03-30 | 2006-11-09 | Astion Development A/S | Treatment or prevention of pruritus |
| AU2006228869A1 (en) * | 2005-03-30 | 2006-10-05 | Astion Pharma A/S | Oxaprozin or a closely related compound for the treatment of eczema |
| DK2340296T3 (da) * | 2008-08-26 | 2015-01-19 | Dorf Ketal Chemicals I Private Ltd | Nyt additiv til inhibering af syrekorrosion og fremgangsmåder til anvendelse af det nye additiv |
| KR20140065862A (ko) * | 2012-11-22 | 2014-05-30 | 에스케이케미칼주식회사 | 발포성 속붕해성 이매티닙 제제 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1206403A (en) * | 1966-12-15 | 1970-09-23 | Wyeth John & Brother Ltd | Oxazoles |
| GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
-
1982
- 1982-03-31 IE IE766/82A patent/IE52909B1/en not_active IP Right Cessation
- 1982-04-05 CA CA000400464A patent/CA1169867A/en not_active Expired
- 1982-04-05 ZA ZA822355A patent/ZA822355B/xx unknown
- 1982-04-06 NZ NZ200247A patent/NZ200247A/en unknown
- 1982-04-06 AU AU82378/82A patent/AU544975B2/en not_active Expired
- 1982-04-06 IL IL65443A patent/IL65443A/xx not_active IP Right Cessation
- 1982-04-07 AT AT82301839T patent/ATE14015T1/de not_active IP Right Cessation
- 1982-04-07 DE DE8282301839T patent/DE3264400D1/de not_active Expired
- 1982-04-07 EP EP82301839A patent/EP0063884B1/en not_active Expired
- 1982-04-09 GR GR67879A patent/GR75913B/el unknown
- 1982-04-15 FI FI821324A patent/FI71314C/fi not_active IP Right Cessation
- 1982-04-15 ZW ZW74/82A patent/ZW7482A1/xx unknown
- 1982-04-22 PH PH27171A patent/PH18053A/en unknown
- 1982-04-23 DK DK183582A patent/DK150604C/da not_active IP Right Cessation
- 1982-04-23 JP JP57069463A patent/JPS57181072A/ja active Granted
- 1982-04-26 PL PL1982236145A patent/PL136322B1/pl unknown
- 1982-04-26 KR KR8201829A patent/KR880000871B1/ko not_active Expired
- 1982-04-26 PT PT74794A patent/PT74794B/pt unknown
- 1982-04-26 US US06/371,904 patent/US4465838A/en not_active Expired - Lifetime
- 1982-04-27 HU HU821325A patent/HU185276B/hu unknown
- 1982-04-27 ES ES511730A patent/ES511730A0/es active Granted
- 1982-04-27 DD DD82239350A patent/DD202017A5/de not_active IP Right Cessation
- 1982-04-28 CS CS823052A patent/CS236674B2/cs unknown
-
1984
- 1984-07-11 US US06/629,704 patent/US4532253A/en not_active Expired - Lifetime
-
1987
- 1987-12-30 MY MY599/87A patent/MY8700599A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3069587D1 (en) | 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof | |
| NL990010I1 (nl) | Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten. | |
| PH18415A (en) | Flavan derivatives,pharmaceutical compositions and use thereof | |
| GB2104079B (en) | New aminoacid isomers, their production and their medicinal use | |
| AU544975B2 (en) | Oxazole derivatives | |
| PH11669A (en) | Thienobenzo(1,5)diazepine derivatives and the pharmaceutical formulation thereof | |
| IL80290A (en) | Oxazole and isoxazole derivatives,their manufacture and pharmaceutical compositions containing them | |
| AU1706788A (en) | 2-(3,4-dihydroxyphenyl)ethylamines, and their use pharmaceutical compositions | |
| ZA832657B (en) | Oxazole derivatives,production and use thereof | |
| FI821288A7 (fi) | Fenetanoliamiini-johdannaisia, niiden valmistus ja niiden terapeuttinen käyttö. | |
| IL65040A0 (en) | Amino-2,1,3-benzothiadiazole and benzoxadiazole derivatives,their preparation and pharmaceutical compositions containing them | |
| PH15625A (en) | Pyridazopyridazine derivatives,their pharmaceutical compositions and their use | |
| GB2104078B (en) | New aminoacid isomers, their production and their medicinal use | |
| PH22848A (en) | 3,3-dialkyl- and 3,3,-alkylene-indoline derivatives, pharmaceutical compositions comprising them and their use | |
| DE68907609D1 (de) | Arzneimittelzusammensetzung. | |
| DE3260949D1 (en) | Benzoyl-phenyl-piperidine derivatives, their preparation and medicinal use | |
| DE3061280D1 (en) | N,n-disubstituted-aminomethyl-phenylethanolamines and pharmaceutical formulations thereof | |
| CA1002051A (en) | Derivatives of 1,4 benzodioxan, the preparation and the use thereof | |
| JPS57158761A (en) | 4(5)-alkylthioimidazole derivative, manufacture and medicinal composition | |
| ZA852367B (en) | New bornane derivatives,their preparation and therapeutic compositions containing the same | |
| IL52350A (en) | Solid sodium amoxycillin,its preparation and pharmaceutical compositions containing it | |
| IT8820572A0 (it) | Agente antitussivo e mucoregolatore, sua preparazione e composizioni farmaceutiche. | |
| ZA821121B (en) | Amino-2,1,3-benzothiadiazole and -benzoxadiazole derivatives, their preparation and pharmaceutical compositions containing them | |
| FI823169A7 (fi) | Antrasykliiniantibioottien 3'- deaminoanalogit, niiden valmistusmenetelmä, koostumus sekä käyttö. | |
| NZ182351A (en) | 1,2,3-triazole derivatives and pharmaceutical compositions |